Alliance Pharma plc DVL.F Stock
Alliance Pharma plc Price Chart
Alliance Pharma plc DVL.F Financial and Trading Overview
| Alliance Pharma plc stock price | 0.41 EUR |
| Previous Close | 0.64 EUR |
| Open | 0.63 EUR |
| Bid | 0.63 EUR x 0 |
| Ask | 0.71 EUR x 0 |
| Day's Range | 0.63 - 0.63 EUR |
| 52 Week Range | 0.39 - 1.38 EUR |
| Volume | 63 EUR |
| Avg. Volume | 7 EUR |
| Market Cap | 354.94M EUR |
| Beta (5Y Monthly) | 0.550574 |
| PE Ratio (TTM) | Infinity |
| EPS (TTM) | -0.02 EUR |
| Forward Dividend & Yield | 0.02 (3.08%) |
| Ex-Dividend Date | June 22, 2023 |
| 1y Target Est | N/A |
DVL.F Valuation Measures
| Enterprise Value | 459.56M EUR |
| Trailing P/E | Infinity |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.1200974 |
| Price/Book (mrq) | 1.1819887 |
| Enterprise Value/Revenue | 2.745 |
| Enterprise Value/EBITDA | 12.633 |
Trading Information
Alliance Pharma plc Stock Price History
| Beta (5Y Monthly) | 0.550574 |
| 52-Week Change | -47.13% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.38 EUR |
| 52 Week Low | 0.39 EUR |
| 50-Day Moving Average | 0.7 EUR |
| 200-Day Moving Average | 0.68 EUR |
DVL.F Share Statistics
| Avg. Volume (3 month) | 7 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 540.14M |
| Float | 467.35M |
| Short Ratio | N/A |
| % Held by Insiders | 11.61% |
| % Held by Institutions | 74.26% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.018 |
| Trailing Annual Dividend Yield | 2.83% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 10.1176 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0.55% |
| Operating Margin (ttm) | 16.98% |
| Gross Margin | 60.73% |
| EBITDA Margin | 21.73% |
Management Effectiveness
| Return on Assets (ttm) | 3.41% |
| Return on Equity (ttm) | 0.32% |
Income Statement
| Revenue (ttm) | 167.42M EUR |
| Revenue Per Share (ttm) | 0.31 EUR |
| Quarterly Revenue Growth (yoy) | 4.79% |
| Gross Profit (ttm) | 101.68M EUR |
| EBITDA | 36.38M EUR |
| Net Income Avi to Common (ttm) | 936K EUR |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 31.71M EUR |
| Total Cash Per Share (mrq) | 0.06 EUR |
| Total Debt (mrq) | 137.58M EUR |
| Total Debt/Equity (mrq) | 47.83 EUR |
| Current Ratio (mrq) | 2.243 |
| Book Value Per Share (mrq) | 0.533 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 20.97M EUR |
| Levered Free Cash Flow (ttm) | 9.75M EUR |
Profile of Alliance Pharma plc
| Country | Germany |
| State | N/A |
| City | Chippenham |
| Address | Avonbridge House |
| ZIP | SN15 2BB |
| Phone | 44 12 4946 6966 |
| Website | https://www.alliancepharmaceuticals.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 285 |
Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics. It provides its products under the Aloclair, Anbesol, Asthon and Parsons, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen brand names. Alliance Pharma plc was incorporated in 1996 and is headquartered in Chippenham, the United Kingdom.
Q&A For Alliance Pharma plc Stock
What is a current DVL.F stock price?
Alliance Pharma plc DVL.F stock price today per share is 0.41 EUR.
How to purchase Alliance Pharma plc stock?
You can buy DVL.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Alliance Pharma plc?
The stock symbol or ticker of Alliance Pharma plc is DVL.F.
Which industry does the Alliance Pharma plc company belong to?
The Alliance Pharma plc industry is Drug Manufacturers-Specialty & Generic.
How many shares does Alliance Pharma plc have in circulation?
The max supply of Alliance Pharma plc shares is 583.65M.
What is Alliance Pharma plc Price to Earnings Ratio (PE Ratio)?
Alliance Pharma plc PE Ratio is now.
What was Alliance Pharma plc earnings per share over the trailing 12 months (TTM)?
Alliance Pharma plc EPS is -0.02 EUR over the trailing 12 months.
Which sector does the Alliance Pharma plc company belong to?
The Alliance Pharma plc sector is Healthcare.